{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T19:29:00Z","timestamp":1776626940479,"version":"3.51.2"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins & Other Lipid Mediators"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.prostaglandins.2025.106988","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T14:10:37Z","timestamp":1743430237000},"page":"106988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["E2F7 upregulates MCM4 and fatty acid metabolism to advance lung adenocarcinoma metastasis"],"prefix":"10.1016","volume":"178","author":[{"given":"WuAsen","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zikang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenggang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2025.106988_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102237","article-title":"Adenocarcinoma spectrum lesions of the lung: detection, pathology and treatment strategies","volume":"99","author":"Succony","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib3","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S1470-2045(23)00444-8","article-title":"Global variations in lung cancer incidence by histological subtype in 2020: a population-based study","volume":"24","author":"Zhang","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00268-018-4848-7","article-title":"Lung Adenocarcinoma has a higher risk of lymph node metastasis than squamous cell carcinoma: a propensity score-matched analysis","volume":"43","author":"Deng","year":"2019","journal-title":"World J. Surg."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib5","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/neuonc\/noad017","article-title":"Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma","volume":"25","author":"Wang","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.lungcan.2020.02.017","article-title":"Stereotatic radiotherapy in metastatic non-small cell lung cancer: Combining immunotherapy and radiotherapy with a focus on liver metastases","volume":"142","author":"Corrao","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib8","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.7150\/ijbs.75284","article-title":"Development and validation of a dna methylation-related classifier of circulating tumour cells to predict prognosis and to provide a therapeutic strategy in lung adenocarcinoma","volume":"18","author":"Gu","year":"2022","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100933","article-title":"CPSF6-mediated XBP1 3\u2032UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma","volume":"68","author":"Zhu","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2019.100646","article-title":"The emergence of drug resistance to targeted cancer therapies: Clinical evidence","volume":"47","author":"Sarmento-Ribeiro","year":"2019","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1101\/gad.335166.119","article-title":"REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors","volume":"34","author":"Qiao","year":"2020","journal-title":"Genes Dev."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib13","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201606","article-title":"Lipid metabolism and cancer","volume":"218","author":"Bian","year":"2021","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib15","first-page":"361","article-title":"Metabolic modulation by butin: protection against high-fat diet-induced obesity in rats via antioxidants\/oxidative stress\/hormonal regulation\/lipid metabolism\/FGF15 signaling pathway","volume":"38","author":"Fahad","year":"2024","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1247\/csf.23016","article-title":"Cell biology of protein-lipid conjugation","volume":"48","author":"Sakamaki","year":"2023","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11110765","article-title":"Fatty acid metabolism reprogramming in advanced prostate cancer","volume":"11","author":"Xu","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042170","article-title":"Fatty acid metabolism in ovarian cancer: therapeutic implications","volume":"23","author":"Yoon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib19","doi-asserted-by":"crossref","first-page":"17847","DOI":"10.18632\/aging.203288","article-title":"Prognostic value of fatty acid metabolism-related genes in patients with hepatocellular carcinoma","volume":"13","author":"He","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib20","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.omto.2021.02.010","article-title":"Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy","volume":"20","author":"Ding","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib21","first-page":"1007","article-title":"A new model based on fatty acid metabolism-related genes to predict the prognosis of esophageal carcinoma","volume":"36","author":"Wenmin","year":"2022","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib22","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.18632\/aging.204725","article-title":"Identification of fatty acid-related subtypes, the establishment of a prognostic signature, and immune infiltration characteristics in lung adenocarcinoma","volume":"15","author":"Wang","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib23","first-page":"63","article-title":"Activation of CTHRC1 by HOXB9 promotes angiogenesis through fatty acid metabolism in lung adenocarcinoma","volume":"75","author":"Liu","year":"2022","journal-title":"Rev. Invest. Clin."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.omtn.2022.11.019","article-title":"The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis","volume":"30","author":"Wang","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/genetics\/106.3.365","article-title":"Mutants of S. cerevisiae defective in the maintenance of minichromosomes","volume":"106","author":"Maine","year":"1984","journal-title":"Genetics"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib26","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/2211-5463.13681","article-title":"Minichromosome maintenance proteins in lung adenocarcinoma: clinical significance and therapeutic targets","volume":"13","author":"Tanigawa","year":"2023","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1266\/ggs.18-00026","article-title":"Regulation of MCM2-7 function","volume":"93","author":"Ishimi","year":"2018","journal-title":"Genes Genet. Syst."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13000-023-01392-y","article-title":"MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma","volume":"18","author":"Kobayashi","year":"2023","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000525590","article-title":"Minichromosome maintenance 4 is associated with cancer stemness and poor survival of patients with gastric cancer","volume":"90","author":"Katsuya","year":"2023","journal-title":"Pathobiology"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7479326","article-title":"Identification of MCM4 as a prognostic marker of hepatocellular carcinoma","volume":"2021","author":"Zhou","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neo.2019.07.011","article-title":"MCM2, MCM4, and MCM6 in breast cancer: clinical utility in diagnosis and prognosis","volume":"21","author":"Issac","year":"2019","journal-title":"Neoplasia"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib32","article-title":"MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma","volume":"12","author":"Yang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib33","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1038\/s41598-024-57299-1","article-title":"Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarker","volume":"14","author":"Li","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib34","article-title":"Potential prospective biomarkers for non-small cell lung cancer: mini-chromosome maintenance proteins","volume":"12","author":"Huang","year":"2021","journal-title":"Front Genet."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib35","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1111\/jcmm.17819","article-title":"MCM4 acts as a biomarker for LUAD prognosis","volume":"27","author":"Tan","year":"2023","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/MMBR.68.1.109-131.2004","article-title":"Eukaryotic MCM proteins: beyond replication initiation","volume":"68","author":"Forsburg","year":"2004","journal-title":"Microbiol Mol. Biol. Rev."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188415","article-title":"MCM family in gastrointestinal cancer and other malignancies: from functional characterization to clinical implication","volume":"1874","author":"Wang","year":"2020","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40291-024-00701-5","article-title":"Unwinding helicase MCM functionality for diagnosis and therapeutics of replication abnormalities associated with cancer: a review","volume":"28","author":"Radhakrishnan","year":"2024","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s41065-023-00280-1","article-title":"EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4","volume":"160","author":"Li","year":"2023","journal-title":"Hereditas"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib41","first-page":"2150","article-title":"E2F2 induces MCM4, CCNE2 and WHSC1 upregulation in ovarian cancer and predicts poor overall survival","volume":"21","author":"Xie","year":"2017","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib42","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.2147\/OTT.S313933","article-title":"Celastrol modulates multiple signaling pathways to inhibit proliferation of pancreatic cancer via DDIT3 and ATF3 up-regulation and RRM2 and MCM4 down-regulation","volume":"14","author":"Youns","year":"2021","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5582\/bst.2021.01016","article-title":"MCM4 in human hepatocellular carcinoma: a potent prognostic factor associated with cell proliferation","volume":"15","author":"Xu","year":"2021","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114613","article-title":"Emerging roles of fatty acid metabolism in cancer and their targeted drug development","volume":"240","author":"An","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120621","article-title":"Fatty acid binding protein 5 regulates lipogenesis and tumor growth in lung adenocarcinoma","volume":"301","author":"Garcia","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib47","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.1111\/jcmm.16815","article-title":"CCAT1\/FABP5 promotes tumour progression through mediating fatty acid metabolism and stabilizing PI3K\/AKT\/mTOR signalling in lung adenocarcinoma","volume":"25","author":"Chen","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib48","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.21037\/tlcr-19-509","article-title":"ACOT11 promotes cell proliferation, migration and invasion in lung adenocarcinoma","volume":"9","author":"Liang","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2024.104321","article-title":"Novel insights into the circadian modulation of lipid metabolism in chicken livers revealed by RNA sequencing and weighted gene co-expression network analysis","volume":"103","author":"Wang","year":"2024","journal-title":"Poult. Sci."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib50","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","article-title":"Targeting transcription factors in cancer - from undruggable to reality","volume":"19","author":"Bushweller","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib51","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41416-020-01032-y","article-title":"E2F7-EZH2 axis regulates PTEN\/AKT\/mTOR signalling and glioblastoma progression","volume":"123","author":"Yang","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib52","article-title":"The roles of E2F7 in cancer: Current knowledge and future prospects","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.prostaglandins.2025.106988_bib53","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41419-022-04624-z","article-title":"SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib54","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41420-022-00925-6","article-title":"Gastric cancer cell-derived extracellular vesicles elevate E2F7 expression and activate the MAPK\/ERK signaling to promote peritoneal metastasis through the delivery of SNHG12","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib55","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00404-018-5007-y","article-title":"E2F7, EREG, miR-451a and miR-106b-5p are associated with the cervical cancer development","volume":"299","author":"Zong","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib56","article-title":"E2F7 transcriptionally inhibits microRNA-199b expression to promote USP47, thereby enhancing colon cancer tumor stem cell activity and promoting the occurrence of colon cancer","volume":"10","author":"Guo","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104677","article-title":"VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner","volume":"299","author":"Zheng","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2025.106988_bib58","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.21873\/anticanres.16688","article-title":"E2F7\/RAD51AP1 axis inhibits endometrial cancer sensitivity to 5-FU via the fatty acid metabolic pathway","volume":"43","author":"Huang","year":"2023","journal-title":"Anticancer Res."}],"container-title":["Prostaglandins & Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882325000413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882325000413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:54:39Z","timestamp":1762365279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882325000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":58,"alternative-id":["S1098882325000413"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2025.106988","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"E2F7 upregulates MCM4 and fatty acid metabolism to advance lung adenocarcinoma metastasis","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2025.106988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106988"}}